Exane Derivatives’s ZENDESK INC ZEN Stock Holding History

Exane Derivatives’s Portfolio ZEN Stock Details ZEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-722	Closed	-$84K	–	1110
2021 Q3	$84K	Buy	+722	New	+$93.3K	0.02%	549
2017 Q2	–	Sell	-1	Closed	-$28	–	686
2017 Q1	$28	Hold	1	–	–	﹤0.01%	540
2016 Q4	$21	Hold	1	–	–	﹤0.01%	613
2016 Q3	$31	Hold	1	–	–	﹤0.01%	580
2016 Q2	$26	Hold	1	–	–	﹤0.01%	516
2016 Q1	$21	Buy	+1	New	+$20	﹤0.01%	573

Other funds holding ZEN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Exane Derivatives's ZEN Position: Q4 2021 in Review

Exane Derivatives sold out of ZENDESK INC (ZEN) in Q4 2021, closing a stake of 722 shares — an estimated $84K sold.

Exane Derivatives first reported a position in ZEN in Q1 2016 and held it in 6 quarters. The position peaked at $84K in Q3 2021. 466 funds tracked by Wall St. Rank hold ZEN as of Q4 2021.

Exane Derivatives reported no remaining ZENDESK INC position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 722 ZENDESK INC shares in Q4 2021, an estimated $84K.
Exane Derivatives first reported a position in ZENDESK INC in Q1 2016 and held it in 6 quarters.
Exane Derivatives's ZENDESK INC position peaked at $84K in Q3 2021.
466 funds tracked by Wall St. Rank held ZENDESK INC as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.